FDA Inspection 783783 — Octapharma AB

Octapharma AB — FEI 3005559915

The FDA completed an inspection of Octapharma AB on January 19, 2012 in Stockholm. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 19, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Stockholm (Sweden)